AstraZeneca (AZN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AstraZeneca

    NASDAQ: AZN · Real-Time Price · USD
    85.31
    1.66 (1.98%)
    At close: Oct 03, 2025, 3:59 PM
    85.31
    0.00%
    After-hours: Oct 03, 2025, 07:53 PM EDT

    AstraZeneca Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 5.49B 5.84B 6.17B 6.33B
    Short-Term Investments
    		 37M 20M 239M 69M
    Long-Term Investments
    		 1.73B 1.78B 903M 1.17B
    Other Long-Term Assets
    		 1.28B 5.65B 1.15B 1.07B
    Receivables
    		 8.3B 8.41B 7.21B 6.03B
    Inventory
    		 5.29B 5.42B 4.7B 8.98B
    Other Current Assets
    		 4.97B 3.75B 3.11B 3.32B
    Total Current Assets
    		 25.83B 25.05B 22.59B 26.24B
    Property-Plant & Equipment
    		 11.65B 10.5B 9.45B 10.17B
    Goodwill & Intangibles
    		 58.2B 58.14B 59.13B 62.38B
    Total Long-Term Assets
    		 78.21B 76.06B 73.89B 79.12B
    Total Assets
    		 104.03B 101.12B 96.48B 105.36B
    Account Payables
    		 3.64B 3.27B 2.55B 2.82B
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 2.16B 5.13B 6.27B 2.66B
    Other Current Liabilities
    		 17.31B 6.13B 3.81B 4.52B
    Total Current Liabilities
    		 27.87B 30.54B 26.29B 22.59B
    Long-Term Debt
    		 26.51B 22.36B 23.91B 29.72B
    Other Long-Term Liabilities
    		 4.37B 8.15B 8.5B 13.01B
    Total Long-Term Liabilities
    		 35.3B 31.41B 33.13B 43.48B
    Total Liabilities
    		 63.16B 61.95B 59.42B 66.08B
    Total Debt
    		 30.11B 28.62B 29.23B 30.78B
    Book Value
    		 40.87B 39.17B 37.06B 39.29B
    Book Value Per Share
    		 13.18 12.54 11.97 13.85
    Common Stock
    		 388M 388M 387M 387M
    Retained Earnings
    		 3.16B 4.52B -574M 1.71B
    Comprehensive Income
    		 n/a n/a -1.63B 111M
    Shareholders Equity
    		 40.79B 39.14B 37.04B 39.27B
    Total Investments
    		 1.9B 1.68B 1.14B 1.24B

    Add to Watchlist